EP Patent

EP2920201A4 — CELL RESPONSIVE, LONG-TERM OR TARGETED CELL-RELEVANT COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

Assigned to Apellis Pharmaceuticals Inc · Expires 2016-10-12 · 10y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP2920201A4
Jurisdiction: EP
Classification: —
Expires: 2016-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Apellis Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.